학력 및 경력사항

• 울산대학교 의과대학 박사
• 울산대학교 의과대학 석사
• 부산대학교 의과대학 졸업

• 2022-현재  | 이대목동병원 혈액종양내과 부교수
• 2020-2022  | 이대목동병원 혈액종양내과 임상부교수
• 2019-2020  | 이대목동병원 혈액종양내과 진료조교수
• 2018-2019  | 인제대학교백병원 혈액종양내과 조교수
• 2015-2017  | 대구가톨릭대학교병원 혈액종양내과 조교수
• 2014-2015  | 서울아산병원 건강의학과 교수
• 2012-2014  | 서울아산병원 종양내과 전임의
• 2007-2011  | 서울아산병원 내과 전공의
• 2005-2006  | 서울아산병원 수련의

• 대한내과학회 정회원
• 대한종양내과학회 정회원
• 대한항암요법연구회 정회원
• 대한암학회 정회원
• 대한혈액학회 정회원

•  Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury.  Journal of Clinical Medicine. 2022, v.11 no.23, 7196. 
•  β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells.  Oncology reports. 2022, v.48 no.1. 
•  Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis.  Biology . 2019-08. 
•  Pharmacological Activation of Sirt1 Ameliorates Cisplatin-Induced Acute Kidney Injury by Suppressing Apoptosis, Oxidative Stress, and Inflammation in Mice.  Antioxitants. 2019-08. 
•  Pharmacological Inhibition of Caspase-1 Ameliorates Cisplatin-Induced Nephrotoxicity through Suppression of Apoptosis, Oxidative Stress, and Inflammation in Mice.  Mediators of Inflammation. 2018-12. 
•  Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.  Cancer Chemotherapy and Pharmacology. 2017-07. 
•  C4d deposits and a new diagnostic modality for amyloidosis.  International Journal of Clinical and Experimental Pathology. 2016-09. 
•  Efficacy of imatinib in patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors.  Cancer Research and Treatment. 2016-04. 
•  Endobronchial mass formation after endobronchial ultrasound–-transbronchial needle aspiration mimicking implantation metastasis.  Clinical Case Reports. 2015-12. 
•  Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.  Lung Cancer. 2014-11. 
•  Abbreviated chemotherapy for limited stage diffuse large B-cell lymphoma after complete resection.  Blood Research. 2014-06. 
•  Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib..  British Journal of Cancer. 2013-10. 
•  Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.  Annals of Oncology. 2013-08. 
•  Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma.  International Journal of Hematology. 2013-02. 
•  Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.  Annals of Hematolgy. 2011-07. 

• [헬스조선] 늦게 발견하면 생존율 뚝 떨어지는 요로상피암… ‘이런 소변’ 보면 검사를 2024-08-28
• [헬스조선] 한국인 10대 암 ‘신장암’, 옆구리 통증·혈뇨 땐 이미 진행 상태 2024-02-01
• [의학신문] 한국머크 요로상피세포암 치료제 바벤시오 2023-12-20
• [코리아헬스로그] [칼럼] 차세대 항암제 ‘항체약물접합체’가 지닌 숙제 2023-12-04

• [건강동영상] 치료 옵션 넓어진 요로상피암, 최근 나온 신약으로 생존율 두 배 증가해 2024-10-08